1. PO.6.131 A randomized, double-blind, placebo controlled study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN-303, a potent dual baff/april inhibitor, in adult healthy volunteers. (27th September 2022) Authors: Harrison, P; Lickliter, J; Dillon, S; Manjarrez, K; Smith, A; Lessig, M; Sanderson, R; Chunyk, A; Zayed, H; Peng, S Journal: Lupus science & medicine Issue: Volume 9(2022)Supplement 2 Page Start: A99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗